Stem Cells Spin Spolka Akcyjna Logo

Stem Cells Spin Spolka Akcyjna

A biotechnology company commercializing research and patents in stem cell technology.

SCS | WAR

Overview

Corporate Details

ISIN(s):
PLSTCLS00013 (+2 more)
LEI:
259400ZBL6DOUA86FW60
Country:
Poland
Address:
WROCŁAW KONOPNICKIEJ 15B, 51-141 WROCŁAW

Description

Stem Cells Spin S.A. is a biotechnology company established in 2009 by scientists from the Medical University of Wroclaw. The company's primary goal is the commercialization of scientific research, inventions, and patents in the field of stem cell technology. Its activities include research and development projects, particularly involving its proprietary MIC-1 stem cells, and participation in biobanking studies to advance scientific applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-07 14:53
Podpisanie listu intencyjnego z inwestorem - Content (PL)
Polish 1.4 KB
2025-06-30 10:15
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 723 bytes
2025-06-04 19:37
Zawarcie umowy o zachowaniu poufności (NDA) w celu przeprowadzenia badania due …
Polish 1.3 KB
2025-05-30 13:51
liczba głosów i akcji w spółce
Polish 684.5 KB
2025-05-30 13:51
wzór pełnomocnictwa
Polish 2.3 MB
2025-05-30 13:51
projekty uchwał
Polish 941.6 KB
2025-05-30 13:51
ogłoszenie o zwołaniu ZWZ
Polish 807.6 KB
2025-05-30 13:51
Zwołanie Zwyczajnego Walnego Zgromadzenia Spółki na 26 czerwca 2025 roku - Cont…
Polish 805 bytes
2024-12-23 20:53
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 726 bytes
2024-11-22 19:34
Otrzymanie przez Marka Cegielskiego - członka Rady Nadzorczej tytułu profesora …
Polish 1.2 KB
2024-11-22 14:22
informacja i liczbie akcji i głosów
Polish 684.5 KB
2024-11-22 14:22
wzór pełnomocnictwa
Polish 2.4 MB
2024-11-22 14:22
projekty uchwał
Polish 1.2 MB
2024-11-22 14:22
treść ogłoszenia o zwołaniu NWZ
Polish 806.7 KB
2024-11-22 14:22
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Spółki na 19 grudnia 2024 roku - C…
Polish 793 bytes

Automate Your Workflow. Get a real-time feed of all Stem Cells Spin Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Stem Cells Spin Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Stem Cells Spin Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.